GENEVA, June 19 -- SYNNOVATION THERAPEUTICS, INC. filed a patent application (US2025/055117) for “HETEROCYCLIC COMPOUNDS AS PARG INHIBITORS”. With publication no. WO/2026/107046, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 403/04
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....